Research articlePublished 12 Jul 2022

Pluripotency Factor PBX1 Predicts Treatment Efficacy in Rheumatoid Arthritis

Authors: Karin M.E. Andersson, Eric Malmhäll-Bah, Nina Y.Oparina, Weiyang Tao, Aridaman Pandit, Malin C. Erlandsson, Venkataragavan Chandrasekaran, Sofia T. Silfverswärd, Rille Pullerits, Maria I. Bokarewa

Journal of Clinical and Cellular Immunology

Volume 13 · Issue 5 · Pages 1–9

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objective: We study molecular mechanisms behind T cell reconstitution in Rheumatoid Arthritis (RA) by asking if PBX1, a transcription factor that maintains stem cell pluripotency, predicts antirheumatic treatment response. Methods: Whole-genome transcriptomics by RNA sequencing was done in CD4+T cells from 87 RA patients with low, and from 78 RA patients with high disease activity. Treatment outcomes in PBX1hi and PBX1lo groups were compared. PBX1-associated phenotype and biological processes were identified by clustering of the genes differentially expressed in PBX1hiCD4+ cells. PBX1hi clusters in thymus were identified by a single cell-based analysis. PBX1 transcriptional targets among DEGs were predicted by the integrative analysis of DNA motif, chromatin immunoprecipitation sequencing and open chromatin data. Results: PBX1hiCD4+ cells had imprinted features of pluripotency and lacked cytokine production. In active RA, PBX1hi cells were enriched with CD34+ pre-thymic lymphocyte progenitors. PBX1hi patients had better reduction of DAS28 on anti-TNF treatment and low frequency of non-responders compared to PBX1lo (both, p=0.026). In inactive RA, PBX1hi cells were enriched with post-thymic naïve T cells expressing CD62L/SELL and CD31/ PECAM1. Here, PBX1hi patients required less treatment to reach remission compared to PBX1lo patients (p=0.011). In thymus, CD34 and PECAM1 were annotated within PBX1hi clusters. Integrative analysis disclosed that central T-cell maturation genes TBX21, PRDM1, BATF3 and KLF1 were transcriptionally dependent on PBX1. Conclusion: This study shows that enrichment for PBX1 is associated with pluripotent phenotype of CD4+ cells, which favours treatment responses in RA.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Karin M.E. Andersson”
  • BylineArticles whose byline prints “Eric Malmhäll-Bah”
  • BylineArticles whose byline prints “Nina Y.Oparina”
  • BylineArticles whose byline prints “Weiyang Tao”
  • BylineArticles whose byline prints “Aridaman Pandit”
  • BylineArticles whose byline prints “Malin C. Erlandsson”
  • BylineArticles whose byline prints “Venkataragavan Chandrasekaran”
  • BylineArticles whose byline prints “Sofia T. Silfverswärd”